Member Login
  1. Stocks
    2. /
  2. HUTCHMED (LSE: HCM)
    3. /

LSE:HCM (HUTCHMED)

About HCM

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • HUTCHMED (LSE: HCM) Latest News

    Investing Articles

    Should You Buy Hikma Pharmaceuticals Plc, Circassia Pharmaceuticals PLC & Hutchison China MediTech Limited On Today’s News?

    | G A Chester

    Can Hikma Pharmaceuticals Plc (LON:HIK), Circassia Pharmaceuticals PLC (LON:CIR) and Hutchison China MediTech Limited (LON:HCM) boost your portfolio?

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc And Hutchison China MediTech Limited Are A Perfect Pairing

    | G A Chester

    G A Chester reckons pairing GlaxoSmithKline plc (LON:GSK) with Hutchison China MediTech Limited (LON:HCM) could be a smart move.

    Read more »

    Investing Articles

    Should You Follow Directors Buying At Monitise Plc, Hutchison China MediTech Limited And Tungsten Corp PLC?

    | G A Chester

    Is it time to invest in Monitise Plc (LON:MONI), Hutchison China MediTech Limited (LON:HCM) and Tungsten Corp PLC (LON:TUNG) after…

    Read more »